These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26256802)

  • 1. Cavities create a potential back door in epoxide hydrolase Rv1938 from Mycobacterium tuberculosis-A molecular dynamics simulation study.
    Selvan A; Anishetty S
    Comput Biol Chem; 2015 Oct; 58():222-30. PubMed ID: 26256802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated computational approach of molecular dynamics simulations, receptor binding studies and pharmacophore mapping analysis in search of potent inhibitors against tuberculosis.
    Agarwal S; Verma E; Kumar V; Lall N; Sau S; Iyer AK; Kashaw SK
    J Mol Graph Model; 2018 Aug; 83():17-32. PubMed ID: 29753941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of an atypical epoxide hydrolase from Mycobacterium tuberculosis gives insights into its function.
    Johansson P; Unge T; Cronin A; Arand M; Bergfors T; Jones TA; Mowbray SL
    J Mol Biol; 2005 Sep; 351(5):1048-56. PubMed ID: 16051262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cloning, expression, purification, crystallization and preliminary X-ray studies of epoxide hydrolases A and B from Mycobacterium tuberculosis.
    Biswal BK; Garen G; Cherney MM; Garen C; James MN
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2006 Feb; 62(Pt 2):136-8. PubMed ID: 16511284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor.
    Biswal BK; Morisseau C; Garen G; Cherney MM; Garen C; Niu C; Hammock BD; James MN
    J Mol Biol; 2008 Sep; 381(4):897-912. PubMed ID: 18585390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The crystal structure of mycobacterial epoxide hydrolase A.
    Schulz EC; Henderson SR; Illarionov B; Crosskey T; Southall SM; Krichel B; Uetrecht C; Fischer M; Wilmanns M
    Sci Rep; 2020 Oct; 10(1):16539. PubMed ID: 33024154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mesT, a unique epoxide hydrolase, is essential for optimal growth of Mycobacterium tuberculosis in the presence of styrene oxide.
    Chownk M; Sharma A; Singh K; Kaur J
    Future Microbiol; 2017 May; 12():527-546. PubMed ID: 28492351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insights into the substrate specificity of a thioesterase Rv0098 of mycobacterium tuberculosis through X-ray crystallographic and molecular dynamics studies.
    Maity K; Bajaj P; Surolia N; Surolia A; Suguna K
    J Biomol Struct Dyn; 2012; 29(5):973-83. PubMed ID: 22292955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
    Kumar R; Garg P; Bharatam PV
    J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The x-ray structure of epoxide hydrolase from Agrobacterium radiobacter AD1. An enzyme to detoxify harmful epoxides.
    Nardini M; Ridder IS; Rozeboom HJ; Kalk KH; Rink R; Janssen DB; Dijkstra BW
    J Biol Chem; 1999 May; 274(21):14579-86. PubMed ID: 10329649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico docking and molecular dynamics simulation of 3-dehydroquinate synthase (DHQS) from Mycobacterium tuberculosis.
    Isa MA; Majumdhar RS; Haider S
    J Mol Model; 2018 May; 24(6):132. PubMed ID: 29752576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and dynamics of Mycobacterium tuberculosis truncated hemoglobin N: insights from NMR spectroscopy and molecular dynamics simulations.
    Savard PY; Daigle R; Morin S; Sebilo A; Meindre F; Lagüe P; Guertin M; Gagné SM
    Biochemistry; 2011 Dec; 50(51):11121-30. PubMed ID: 21999759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: Insights into residues with potential significance in cyclopropanation.
    Annaraj P D; Kadirvel P; Subramanian A; Anishetty S
    J Mol Graph Model; 2019 Sep; 91():61-71. PubMed ID: 31181453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring
    Mitusińska K; Magdziarz T; Bzówka M; Stańczak A; Gora A
    Biomolecules; 2018 Nov; 8(4):. PubMed ID: 30424576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homology modelling and site-directed mutagenesis studies of the epoxide hydrolase from Phanerochaete chrysosporium.
    Zhang LF; Wu JM; Feng H
    J Biochem; 2011 Jun; 149(6):673-84. PubMed ID: 21292804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanistic insights from molecular dynamic simulation of Rv0045c esterase in Mycobacterium tuberculosis.
    Sherlin D; Anishetty S
    J Mol Model; 2015 Apr; 21(4):90. PubMed ID: 25783994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epoxide Hydrolase Conformational Heterogeneity for the Resolution of Bulky Pharmacologically Relevant Epoxide Substrates.
    Serrano-Hervás E; Casadevall G; Garcia-Borràs M; Feixas F; Osuna S
    Chemistry; 2018 Aug; 24(47):12254-12258. PubMed ID: 29633396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MM2QM tool for combining docking, molecular dynamics, molecular mechanics, and quantum mechanics.
    Nowosielski M; Hoffmann M; Kuron A; Korycka-Machala M; Dziadek J
    J Comput Chem; 2013 Apr; 34(9):750-6. PubMed ID: 23233437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of epoxide hydrolase 2 from Mangifera indica throws light on the substrate specificity determinants of plant epoxide hydrolases.
    Bhoite A; Gaur NK; Palange M; Kontham R; Gupta V; Kulkarni K
    Biochem Biophys Res Commun; 2024 Nov; 733():150444. PubMed ID: 39067247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular modeling and docking studies of O-succinylbenzoate synthase of M. tuberculosis--a potential target for antituberculosis drug design.
    Pulaganti M; Banaganapalli B; Mulakayala C; Chitta SK; C M A
    Appl Biochem Biotechnol; 2014 Feb; 172(3):1407-32. PubMed ID: 24203275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.